Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor
Shouhong Xuan, … , Domenico Accili, Argiris Efstratiadis
Shouhong Xuan, … , Domenico Accili, Argiris Efstratiadis
Published October 1, 2002
Citation Information: J Clin Invest. 2002;110(7):1011-1019. https://doi.org/10.1172/JCI15276.
View: Text | PDF
Categories: Article Endocrinology

Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor

  • Text
  • PDF
Abstract

Research Article

Authors

Shouhong Xuan, Tadahiro Kitamura, Jun Nakae, Katerina Politi, Yoshiaki Kido, Peter E. Fisher, Manrico Morroni, Saverio Cinti, Morris F. White, Pedro L. Herrera, Domenico Accili, Argiris Efstratiadis

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Generation of a conditional IGF1R knockout in β cells. (a) A diagram of ...
Generation of a conditional IGF1R knockout in β cells. (a) A diagram of the Igf1r locus around exon 3 (filled square) is shown, followed by diagrams of the null (Igf1r+/–) (41), floxed (Igf1rlox) (42), and recombined floxed (Igf1rΔlox) (42) alleles. The positions of the P1, P2, and P3 primers (arrows) used for genotyping are indicated. (b) PCR analyses using DNA from islets and control tissues. The lanes labeled – and + correspond to the negative and positive controls. Primers P1 and P2 yield a product of approximately 120 bp in WT and null Igf1r alleles, and 220 bp in the Igf1rlox allele. In the Igf1rΔlox allele, excision of exon 3 enables amplification to occur between primers P3 and P2, yielding 320 bp. In the lanes to the right of the markers, DNA from different tissues of Igf1rΔlox/– mice was used. Br, brain; Li, liver; and Ki, kidney. (c) Western blot analysis of IGF1R expression. We obtained protein extracts from wild-type mouse embryonic fibroblasts or from fibroblasts derived from Igf1r–/– mice as positive and negative controls (first two lanes on the left). We purified islets from wild-type (third lane from the left) and Igf1rΔlox/– mice (right lane). Following detection of IGF1R, the blot was stripped and reprobed with anti-tubulin antiserum. The position of the various bands is indicated on the left of the autoradiogram.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts